SPECTRAL AI INC
MDAINASDAQTrading Snapshot
- Day Range
- $1.55 – $1.58
- 52-Week Range
- $1.18 – $2.97
- Volume
- $2.32B
- Avg Volume
- $2.14B
- Shares Outstanding
- 31.8M
- Next Earnings
- Sep 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $20M
- Last Q Revenue
- $4M
- P/E Ratio
- —
- P/S Ratio
- 3.2x
- EPS (TTM)
- $-0.52
- Dividend Yield
- —
Why Investors Own MDAI
- ✓High-growth profile — revenue up +48.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 36% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About SPECTRAL AI INC
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript
Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call August 11, 2026 5:00 PM EDTCompany ParticipantsVincent Capone - CEO & Corporate SecretaryDavid McGuire -...
Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call
DALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2026 on Tuesday, August 11, 2026, after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the s